Role of the renin-angiotensin system in the development of thyroxine-induced hypertension

European Journal of Endocrinology

Volumn 136, Issue 6, 1997, Pages 656-660

  Rio, Cipriano Garcia Del ^a,b,c   Moreno, Maria Rosario R ^a,b,c   Osuna, Antonio ^a,b,c   De Luna, Juan Dios ^a,b,c   Garcia Estan, Joaquin ^a,b,c   Vargas, Félix ^a,b,c  

^a Departamentos de Fisiologia Y Bioestadistica   (Spain)

^b Facuhades de Medicina de Granada Y Murcia   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; THYROXINE;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; HYPERTHYROIDISM; KIDNEY FUNCTION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0030807999     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1360656     Document Type: Article

References (28)

1. Bradley SE, Stephan F, Coelho JB & Reville P. The thyroid and the kidney. Kidney International 1974 6 346-365.
2. Klein I. Thyroid hormone and the cardiovascular system. American Journal of Medicine 1990 88 631-637.
3. Klein I & Ojamaa K. Thyroid hormone and blood pressure regulation. In Hypertension: Palhophysiology, Diagnosis and Management, edn 2, pp 2247-2262. Eds JH Laragh & BN Brenner. New York: Raven Press Ltd, 1995.
4. Vargas F, Baz MJ, Luna JD, Andrade J, Jodar E & Haro JM. Urinary excretion of digoxin-like immunoreactive factor and argininevasopressin in hyper- and hypo-thyroid rats. Clinical Science 1991 81 471-476.
5. Vargas F, Atucha N, Sabio JM, Quesada T & Garcia-Estan J. Pressure-diuresis-natriuresis response in hyper- and hypothyroid rats. Clinical Science 1994 87 323-328.
6. Guyton AC. Arterial Pressure and Hypertension. Philadelphia: Saunders, 1980.
7. Dahlöf B. Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy: A review. Drugs 1988 35 (Suppl 6) 6-26.
8. Morgan HE & Baker KM. Cardiac hypertrophy: mechanical, neural, and endocrine dependence. Circulation 1991 83 13-25.
9. Hauger-Klevene JH, De Vito E & Fasciolo JC. The effect of thyroid hormone and renin production and release by rat kidney slices. Acta Physiologica et Pharmacologica Latinoamerica 1977 27 37-43.
10. Ganong WE Thyroid hormones and renin secretion. Life Sciences 1982 30 577-584.
11. Jiménez E, Montiel M, Narvaez JA & Morel M. Effects of hyper and hypothyroidism on the basal levels of angiotensin I and kinetic parameters of renin angiotensin system in male rats. Revista Espanola de Fisiologia 1982 38 149-154.
12. Marchant C, Brown L & Sernia C. Renin-angiotensin system in thyroid dysfunction in rats. Journal of Cardiovascular Pharmacology 1993 22 449-455.
13. Garcîa-Estan J. Atucha N, Quesada T & Vargas F. Involvement of the renin-angiotensin system in the reduced pressure-natriuresis response of hyperthyroid rats. American Journal of Physiology 1995 268E897-E901.
14. Coulombe P, Dussault JH & Walker P. Plasma catecholamine concentrations in hyperthyroidism and hypothyroidism. Metabolism 197625 973-978.
15. Beaven MA, Costa E & Brodie BB. The turnover of norepinephrine in thyrotoxic and non-thyrotoxic mice. Life Sciences 19634241246.
16. Levey GS. Catecholamine sensitivity, thyroid hormone and the heart. American Journal of Medicine 1971 50413-420.
17. Krawietz W, Wierdan K & Erdmann E. Effects of thyroid status on beta-adrenergic receptor adenylate cyclase activity and guanine nucleotide regulatory unit in rat cardiac and erythrocyte membranes. Biochemical Pharmacology 1982 31 2463-2467.
18. Haro JM, Sabio JM & Vargas F. Renal beta-adrenoceptors in thyroxine-treated rats. Journal of Endocrinological Investigation 1992 15 605-608.
19. Klein I. Thyroxine-induced cardiac hypertrophy: time course of development and inhibition by propranolol. Endocrinology 1988 123203-210.
20. Rodger RL & McNeill JH. Antihypertensive effect of thyroidectomy in SHR: associated changes in heart performance. American Journal of Physiology 1986 250 H600-H605.
21. Bedotto JB, Gay RG, Graham SD. Morkin E & Goldman S. Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade. Journal of Pharmacology and Experimental Therapeutics 1989 248 632636.
22. Nagano M, Higaki J, Mikami H, Nakamaru M, Higashimori K, Katahira K et al. Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats. Journal of Hypertension 1992 10 1165-1171.
23. Ferrone RA & Antonaccio MJ. Prevention of the development of spontaneous hypertension in rats by captopril. European Journal of Pharmacology 1979 60 131-137.
24. McLennan GP, Kline RL & Mercer PF. Effect of enalapril treatment on the pressure-natriuresis curve in spontaneously hypertensive rals. Hypertension 1991 17 54-62.
25. Cutler RE. Glatte H & Dowling JT. Effect of hyperthyroidism on the renal concentrating mechanism in humans. Journal of Clinical Endocrinology 1967 27 453-460.
26. Ford RV, Owens JC. Curd GW, Moyer SH & Spurr CL. Kidney function in various thyroid states. Journal of Clinical Endocrinology and Metabolism 1961 21 548-553.
27. Katz AI & Lindheimer MD. Renal sodium- and potassiumactivated adenosine triphosphatase and sodium reabsorption in the hypothyroid rat. Journal of Clinical Investigation 1973 52 796-804.
28. Garg LC & Tisher CC. Effects of thyroid hormone on Na-K-adenosine triphosphatase activity along the rat nephron. Journal of Laboratory and Clinical Medicine 1985 106 568-572.